Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 13

1.

Adenoviral gene therapy for pancreatic cancer: where do we stand?

Kuhlmann KF, Gouma DJ, Wesseling JG.

Dig Surg. 2008;25(4):278-92. doi: 10.1159/000145981. Epub 2008 Jul 17. Review.

2.

Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer.

Burton JB, Johnson M, Sato M, Koh SB, Mulholland DJ, Stout D, Chatziioannou AF, Phelps ME, Wu H, Wu L.

Nat Med. 2008 Aug;14(8):882-8. doi: 10.1038/nm.1727. Epub 2008 Jul 11.

3.

Adenoviral vectors for gene therapy.

Douglas JT.

Mol Biotechnol. 2007 May;36(1):71-80. Review.

PMID:
17827541
4.

Adenoviral vectors--how to use them in cancer gene therapy?

Majhen D, Ambriović-Ristov A.

Virus Res. 2006 Aug;119(2):121-33. Epub 2006 Mar 14. Review.

PMID:
16533542
6.
7.

Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy.

Sato M, Johnson M, Zhang L, Zhang B, Le K, Gambhir SS, Carey M, Wu L.

Mol Ther. 2003 Nov;8(5):726-37.

8.

Interrogating androgen receptor function in recurrent prostate cancer.

Zhang L, Johnson M, Le KH, Sato M, Ilagan R, Iyer M, Gambhir SS, Wu L, Carey M.

Cancer Res. 2003 Aug 1;63(15):4552-60.

9.

Molecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer.

Zhang L, Adams JY, Billick E, Ilagan R, Iyer M, Le K, Smallwood A, Gambhir SS, Carey M, Wu L.

Mol Ther. 2002 Mar;5(3):223-32.

10.

Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters.

Iyer M, Wu L, Carey M, Wang Y, Smallwood A, Gambhir SS.

Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14595-600.

11.

Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors.

Wu L, Matherly J, Smallwood A, Adams JY, Billick E, Belldegrun A, Carey M.

Gene Ther. 2001 Sep;8(18):1416-26.

12.

Gene therapy: designer promoters for tumour targeting.

Nettelbeck DM, Jérôme V, Müller R.

Trends Genet. 2000 Apr;16(4):174-81. Review.

PMID:
10729833
13.

GAL4-VP16 is an unusually potent transcriptional activator.

Sadowski I, Ma J, Triezenberg S, Ptashne M.

Nature. 1988 Oct 6;335(6190):563-4.

PMID:
3047590

Supplemental Content

Support Center